Sodium Hyaluronate Ingredient
Sodium Hyaluronate Powder Manufacturer & Supplier
Food-grade sodium hyaluronate powder for supplement and nutrition formulations. The supplied grade includes a measured molecular-weight value, allowing formulators to match the material to the intended product format and processing conditions.
Product Information
Food-Grade Sodium Hyaluronate Powder
The core identity and supplied product form.
Formulation Consideration
Molecular Weight & Formulation Behavior
Molecular weight is an important sodium hyaluronate parameter because it can affect viscosity and solution behavior. The appropriate material depends on the finished formula and processing conditions.
Solid Dosage & Powder Formats
For capsules, tablets and dry blends, powder handling, moisture and bulk density are relevant to manufacturing performance.
Reconstituted & Liquid Systems
For products that are dissolved or reconstituted, viscosity, pH and solution appearance become more important during formulation work.
Certificate of Analysis
Batch Specification & Analytical Results
Specifications and measured results for the documented food-grade production batch.
| Test Item | Standard | Specification | Result |
|---|---|---|---|
| Appearance | QB/T 4576-2023 | White or almost white powder or granular | Qualified |
| Sodium Hyaluronate | QB/T 4576-2023 | ≥92.0% | 93.08% |
| Glucuronic Acid | QB/T 4416-2012 | ≥43.5% | 45.02% |
| Molecular Weight | QB/T 4416-2012 | Measured Value | 1.048 × 106 Da |
| pH (0.1%) | QB/T 4576-2023 | 6.0–8.0 | 7.10 |
| Loss on Drying | QB/T 4576-2023 | ≤10.0% | 8.0% |
| Residue on Ignition | QB/T 4576-2023 | ≤13.0% | 9.25% |
| Protein | EP10.0 | ≤0.30% | 0.168% |
| Transmittance (0.1%) | QBT 4416-2012 | ≥99.0% | 99.9% |
| Bulk Density | CP 2020 | Measured Value | 0.30 g/ml |
| Sulphate | WS1-(X072) 2011Z | ≤0.02 | <0.02 |
| Total Arsenic (as As) | QB/T 4576-2023 | ≤0.3 mg/kg | <0.3 mg/kg |
| Heavy Metal (as Pb) | QB/T 4576-2023 | ≤0.5 mg/kg | <0.5 mg/kg |
| Hg | T-SNHFA011-2021 | ≤0.1 mg/kg | <0.1 mg/kg |
| Cd | T-SNHFA011-2021 | ≤0.5 mg/kg | <0.5 mg/kg |
| Total Plate Counts | QB/T 4576-2023 | ≤100 CFU/g | <100 CFU/g |
| Molds & Yeasts | QB/T 4576-2023 | ≤50 CFU/g | <50 CFU/g |
| Staphylococcus Aureus | T-SNHFA011-2021 | Negative | Negative |
| Pseudomonas Aeruginosa | QB/T 4416-2012 | Negative | Negative |
| Coli Group | QB/T 4576-2023 | Negative | Negative |
The certificate concludes that the batch complies with the stated internal control standard.
Applications
Sodium Hyaluronate Applications
Used across solid and reconstituted supplement formats, with formulation requirements varying by dosage form and process.
Joint-Health Formulas
Used in joint-health supplement formulas as a standalone or combination ingredient.
Beauty-from-Within
Used in oral beauty formulas where Sodium Hyaluronate is selected as part of a skin-focused ingredient system.
Capsules & Tablets
Suitable for solid-dose products when the selected material fits the target serving and manufacturing process.
Powders & Drinks
Used in powder and beverage concepts where the ingredient is incorporated directly or dissolved during formulation.
Discuss Your Sodium Hyaluronate Project
Send your inquiry and our team will follow up directly to continue the commercial discussion.
Inquiry Review
Your message is routed for product and commercial follow-up.
Direct Follow-Up
A member of our team responds to continue the discussion with you.
Next-Step Coordination
Further requests can be coordinated directly as the project moves forward.